Nuclear factor (erythroid-derived 2)-like 2 promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma

被引:0
|
作者
Leung, Hoi Wing [1 ]
Lee, Terence Kin Wah [1 ]
机构
[1] Hong Kong Polytech Univ, Hong Kong, Peoples R China
关键词
D O I
10.1158/1538-7445.AM2018-1996
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1996
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Basic Concepts on the Role of Nuclear Factor Erythroid-Derived 2-Like 2 (Nrf2) in Age-Related Diseases
    Francisqueti-Ferron, Fabiane Valentini
    Togneri Ferron, Artur Junio
    Garcia, Jessica Leite
    Vagula de Almeida Silva, Carol Cristina
    Costa, Mariane Rovero
    Gregolin, Cristina Schmitt
    Moreto, Fernando
    Ferreira, Ana Lucia A.
    Minatel, Igor Otavio
    Correa, Camila Renata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13)
  • [42] Impact of nuclear factor erythroid-derived 2-like 2 and p62/sequestosome expression on prognosis of patients with gliomas
    Zhao, Mingfei
    Xu, Hangdi
    Zhang, Buyi
    Hong, Bo
    Yan, Wei
    Zhang, Jianmin
    HUMAN PATHOLOGY, 2015, 46 (06) : 843 - 849
  • [43] GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers
    Rasheed, Suhail Ahmed Kabeer
    Leong, Hui Sun
    Lakshmanan, Manikandan
    Raju, Anandhkumar
    Dadlani, Dhivya
    Chong, Fui-Teen
    Shannon, Nicholas B.
    Rajarethinam, Ravisankar
    Skanthakumar, Thakshayeni
    Tan, Ern Yu
    Hwang, Jacqueline Siok Gek
    Lim, Kok Hing
    Tan, Daniel Shao-Weng
    Ceppi, Paolo
    Wang, Mei
    Tergaonkar, Vinay
    Casey, Patrick J.
    Iyer, N. Gopalakrishna
    ONCOGENE, 2018, 37 (10) : 1340 - 1353
  • [44] GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers
    Suhail Ahmed Kabeer Rasheed
    Hui Sun Leong
    Manikandan Lakshmanan
    Anandhkumar Raju
    Dhivya Dadlani
    Fui-Teen Chong
    Nicholas B Shannon
    Ravisankar Rajarethinam
    Thakshayeni Skanthakumar
    Ern Yu Tan
    Jacqueline Siok Gek Hwang
    Kok Hing Lim
    Daniel Shao-Weng Tan
    Paolo Ceppi
    Mei Wang
    Vinay Tergaonkar
    Patrick J. Casey
    N. Gopalakrishna Iyer
    Oncogene, 2018, 37 : 1340 - 1353
  • [45] Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines
    Skowron, Margaretha A.
    Niegisch, Guenter
    Albrecht, Philipp
    van Koeveringe, Gommert
    Romano, Andrea
    Albers, Peter
    Schulz, Wolfgang A.
    Hoffmann, Michele J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [46] Evaluation of antioxidant activation by potential nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/Keap1 complex inhibitors
    Almazari, Inas Saleh
    Elhayek, Shada Youssef
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (09) : 1861 - 1873
  • [47] Identification and characterisation of a G-quadruplex forming sequence in the promoter region of nuclear factor (erythroid-derived 2)-like 2 (Nrf2)
    Waller, Zoe A. E.
    Howell, Lesley A.
    MacDonald, Colin J.
    O'Connell, Maria A.
    Searcey, Mark
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 447 (01) : 128 - 132
  • [48] Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis
    Anisha A. Gupte
    Christopher J. Lyon
    Willa A. Hsueh
    Current Diabetes Reports, 2013, 13 : 362 - 371
  • [49] SIRT2 MEDIATED-DEACETYLATION OF NUCLEAR FACTOR ( ERYTHROID-DERIVED 2)-LIKE 2 (NRF2) REGULATES CELLULAR IRON HOMEOSTASIS
    Yang, Xiaoyan
    Vassilopoulos, Athanasios
    Park, Seong-Hoon
    Gius, David
    Ardehali, Hossein
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : E117 - E117
  • [50] Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis
    Gupte, Anisha A.
    Lyon, Christopher J.
    Hsueh, Willa A.
    CURRENT DIABETES REPORTS, 2013, 13 (03) : 362 - 371